v3.24.2.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Sales $ 9,443 $ 7,183 $ 17,826 $ 13,881
Cost of goods sold [1],[2] 8,092 6,331 15,689 12,750
Gross profit 1,351 852 2,137 1,131
Operating expenses:        
Research and development [1],[2] 4,519 3,526 8,006 7,102
Selling, general and administrative [1],[2] 10,696 16,704 18,294 32,685
Total operating expenses 15,215 20,230 26,300 39,787
Loss from operations (13,864) (19,378) (24,163) (38,656)
Other income (expense):        
Change in fair value of warrant liability 1,096 15,151 (3,084) 15,151
Interest expense, net (12,500) (6,472) (22,108) (10,771)
Other income 1 23 38 73
Net loss $ (25,267) $ (10,676) $ (49,317) $ (34,203)
Net loss applicable to common stockholders per common share:        
Basic (in dollars per share) $ (3.00) $ (1.35) $ (5.89) $ (4.37)
Diluted (in dollars per share) $ (3.00) $ (1.35) $ (5.89) $ (4.37)
Weighted average common shares outstanding:        
Basic (in shares) 8,411,226 7,930,371 8,368,596 7,829,673
Diluted (in shares) 8,411,226 7,930,371 8,368,596 7,829,673
[1] Amounts include depreciation and amortization as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2024 2023 2024 2023
Cost of goods sold
$ 1,352  $ 894  $ 2,555  $ 1,830 
Research and development
1,382  466  2,179  1,032 
Selling, general and administrative
1,155  1,956  2,383  3,912 
Total depreciation and amortization $ 3,889  $ 3,316  $ 7,117  $ 6,774 
[2] Amounts include stock-based compensation as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2024 2023 2024 2023
Cost of goods sold
$ 39  $ (11) $ 60  $ 76 
Research and development
71  595  164  1,333 
Selling, general and administrative
1,538  3,850  490  8,984 
Total stock-based compensation expense, net of amounts capitalized $ 1,648  $ 4,434  $ 714  $ 10,393 

Source